Autologous Cell Therapy Market Size by Product, Type, Application, End-User, Region – Revenue Pool A
Autologous cell therapy is a personalized treatment that uses a patient\'s own cells, which are harvested, processed (often genetically modified or expanded ex vivo), and then reintroduced into the same patient to treat diseases such as cancers, autoimmune disorders, or tissue damage. This approach reduces immune rejection risks and enables analog therapy. Autologous cell therapy market is a rapidly growing due to focus on individual remedies using his own cells, mainly for oncology (eg, CAR-T) and regenerative therapy (eg, chondocytes, stem cells).